Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cancer Registry Software Market, by Type
1.4.2 Europe Cancer Registry Software Market, by Deployment Type
1.4.3 Europe Cancer Registry Software Market, by Component
1.4.4 Europe Cancer Registry Software Market, by End User
1.4.5 Europe Cancer Registry Software Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Cancer Registry Software Market by Type
3.1 Europe Integrated Cancer Registry Software Market by Country
3.2 Europe Standalone Cancer Registry Software Market by Country
Chapter 4. Europe Cancer Registry Software Market by Deployment Model
4.1 Europe On-premise Cancer Registry Software Market by Country
4.2 Europe Cloud-based Cancer Registry Software Market by Country
Chapter 5. Europe Cancer Registry Software Market by Component
5.1 Europe Commercial Cancer Registry Software Market by Country
5.2 Europe Public Cancer Registry Software Market by Country
Chapter 6. Europe Cancer Registry Software Market by End User
6.1 Europe Government & Third party Market by Country
6.2 Europe Research Centers Market by Country
6.3 Europe Hospital & Medical Centers Market by Country
6.4 Europe Private Payers Market by Country
6.5 Europe Pharma biotech & medical device suppliers Market by Country
Chapter 7. Europe Cancer Registry Software Market by Country
7.1 Germany Cancer Registry Software Market
7.1.1 Germany Cancer Registry Software Market by Type
7.1.2 Germany Cancer Registry Software Market by Deployment Model
7.1.3 Germany Cancer Registry Software Market by Component
7.1.4 Germany Cancer Registry Software Market by End User
7.2 UK Cancer Registry Software Market
7.2.1 UK Cancer Registry Software Market by Type
7.2.2 UK Cancer Registry Software Market by Deployment Model
7.2.3 UK Cancer Registry Software Market by Component
7.2.4 UK Cancer Registry Software Market by End User
7.3 France Cancer Registry Software Market
7.3.1 France Cancer Registry Software Market by Type
7.3.2 France Cancer Registry Software Market by Deployment Model
7.3.3 France Cancer Registry Software Market by Component
7.3.4 France Cancer Registry Software Market by End User
7.4 Russia Cancer Registry Software Market
7.4.1 Russia Cancer Registry Software Market by Type
7.4.2 Russia Cancer Registry Software Market by Deployment Model
7.4.3 Russia Cancer Registry Software Market by Component
7.4.4 Russia Cancer Registry Software Market by End User
7.5 Spain Cancer Registry Software Market
7.5.1 Spain Cancer Registry Software Market by Type
7.5.2 Spain Cancer Registry Software Market by Deployment Model
7.5.3 Spain Cancer Registry Software Market by Component
7.5.4 Spain Cancer Registry Software Market by End User
7.6 Italy Cancer Registry Software Market
7.6.1 Italy Cancer Registry Software Market by Type
7.6.2 Italy Cancer Registry Software Market by Deployment Model
7.6.3 Italy Cancer Registry Software Market by Component
7.6.4 Italy Cancer Registry Software Market by End User
7.7 Rest of Europe Cancer Registry Software Market
7.7.1 Rest of Europe Cancer Registry Software Market by Type
7.7.2 Rest of Europe Cancer Registry Software Market by Deployment Model
7.7.3 Rest of Europe Cancer Registry Software Market by Component
7.7.4 Rest of Europe Cancer Registry Software Market by End User
Chapter 8. Company Profiles
8.1 IBM Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 McKesson Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Conduent, Incorporated
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expense
8.3.4 Recent strategies and developments:
8.3.4.1 Product Launches and Product Expansions:
8.4 Elekta AB
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Ordinal Data, Inc.
8.5.1 Company Overview
8.6 Onco, Inc.
8.6.1 Company Overview
8.7 C/Net Solutions
8.7.1 Company Overview
8.8 Rocky Mountain Cancer Data System
8.8.1 Company Overview
8.9 Electronic Registry System, Inc.
8.9.1 Company Overview
8.1 Himagine Solutions, Inc.
8.10.1 Company Overview
Unique Offerings 